ID: ALA5280709

Max Phase: Preclinical

Molecular Formula: C38H53NO8

Molecular Weight: 651.84

Associated Items:

Representations

Canonical SMILES:  CO[C@@]12Nc3cccc(CC4OC4(C)C)c3[C@]1(O)C[C@@H]1CC[C@@]3(O)[C@@]45O[C@@H]4[C@@H]4O[C@H](C=C(C)C)OC(C)(C)[C@H]4O[C@H]5CC[C@]3(C)[C@]12C

Standard InChI:  InChI=1S/C38H53NO8/c1-20(2)17-26-44-28-29(32(5,6)46-26)43-24-14-15-33(7)34(8)22(13-16-36(33,41)37(24)30(28)47-37)19-35(40)27-21(18-25-31(3,4)45-25)11-10-12-23(27)39-38(34,35)42-9/h10-12,17,22,24-26,28-30,39-41H,13-16,18-19H2,1-9H3/t22-,24-,25?,26-,28+,29-,30+,33+,34-,35+,36-,37-,38+/m0/s1

Standard InChI Key:  WSSPQHFLVBEQBI-FXWBJDMXSA-N

Associated Targets(Human)

Acyl coenzyme A:cholesterol acyltransferase 1 857 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Acyl coenzyme A:cholesterol acyltransferase 2 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 651.84Molecular Weight (Monoisotopic): 651.3771AlogP: 5.10#Rotatable Bonds: 4
Polar Surface Area: 114.47Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.95CX Basic pKa: CX LogP: 5.21CX LogD: 5.21
Aromatic Rings: 1Heavy Atoms: 47QED Weighted: 0.30Np Likeness Score: 1.73

References

1. Bhattacharjee P, Rutland N, Iyer MR..  (2022)  Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.,  65  (24.0): [PMID:36473091] [10.1021/acs.jmedchem.2c01265]

Source